| abstract |
(57) Abstract The present invention relates to substituted heteroaromatic compounds, particularly substituted quinolines and quinazolines, which are protein tyrosine kinase inhibitors. These preparations, pharmaceutical compositions containing such compounds, and for example psoriasis, fibrosis, atherosclerosis, restenosis, autoimmune diseases, allergies, asthma, transplant rejection, inflammation, thrombosis, nervous system The use of those medicaments in the treatment of diseases and cancer. |